SRTD Biotech raises €31.5 million for targeted RNA therapies

Image: Primary

Published Monday, November 9, 2026 · 9:06 AM EST

SRTD Biotech has completed an oversubscribed €31.5 million seed financing to develop RNA therapies designed to act selectively inside diseased cells. Mérieux Equity Partners led the round, with NRW.BANK and Boehringer Ingelheim Venture Fund joining as co-leads. The Jülich-based company says its technology uses RNA markers inside cells to activate therapeutic payloads in target cells while limiting exposure in healthy tissue. Its platform also combines delivery technology with synthetic biology and AI-driven RNA design. Following the financing, Matthias Alder was appointed chief executive. He said the proceeds would support development of the company's RNA therapeutics; safer and more effective treatments remain its development goal.

Sources

EU-Startups

Published by Tech & Business, a media brand covering technology and business. This story was sourced from EU-Startups and reviewed by the T&B editorial agent team.

Back to Newswire

Keep reading

Full wire

Capital Products

U.S. Series A funding reaches $42 billion as deal counts hold steady

U.S. startups raised $42 billion in Series A funding through October 2026, up roughly 60% year over year, while deal counts remained on pace with recent years, Crunchbase data shows.

Products

Ardian raises €1 billion for European semiconductor investment platform

Ardian has raised €1 billion for its debut semiconductor investment platform, including nearly €700 million ($781 million) in fund commitments alongside co-investments, according to a statement reviewed by Bloomberg.

Capital

Nominal raises $240 million at a $3 billion valuation

Nominal has raised $240 million at a $3 billion valuation, triple its valuation in a funding round earlier this year, Bloomberg reports. The startup builds software to make manufacturing more efficient.

Capital Products

Onodrim raises $300M to acquire European defence and industrial suppliers

Amsterdam-based Onodrim Industries has raised $300M in a round led by Lux Capital, valuing the defence group at $1.3bn, the company said Monday. Other investors include General Catalyst, Lakestar and Altimeter. The financing follows its €40M seed round in February.

Ingenix claims biological reasoning benchmark lead, announces open-source version

Ingenix says its 9-billion-parameter Thalamus Reasoning model ranks first among 29 models on LongevityBench, which tests language models on cellular aging research.

Capital AI

AI publishing platform Spines raises $29M in equity and $35M in debt

Spines raised $29M in equity and $35M in debt, Globes reported. The Herzliya-based company lets amateur authors upload manuscripts to a platform where AI agents edit and proofread their books, design covers and handle page layout.